Position in LLY
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$30,735,396
+$17,024,385 QoQ
Shares Held
25,625
+71.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#709
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2026CallValue
$599,715
CallShares
500
PutValue
$719,658
PutShares
600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MISSION WEALTH MANAGEMENT, LP holds $105,799,986 across 14 Drug Manufacturers - General names. LLY ranks #1 (29.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
25,625 | $30,735,396 | |
| 2 | JNJ |
Johnson & Johnson
|
96,816 | $24,588,359 | |
| 3 | ABBV |
AbbVie Inc.
|
69,052 | $17,376,245 | |
| 4 | MRK |
Merck & Co., Inc.
|
72,281 | $9,288,108 | |
| 5 | AMGN |
Amgen Inc
|
25,436 | $9,210,884 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
59,419 | $3,423,722 | |
| 7 | NVS |
Novartis AG
|
19,690 | $3,085,816 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
16,879 | $2,132,492 |
All Filings in LLY
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,735,396 | 25,625 | Shares | Sole | 2026-07-20 | |
| 2026-06-30 | $599,715 | 500 | Call | Sole | 2026-07-20 | |
| 2026-06-30 | $719,658 | 600 | Put | Sole | 2026-07-20 | |
| 2026-03-31 | $13,711,011 | 14,907 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $1,655,586 | 1,800 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $2,149,360 | 2,000 | Put | Sole | 2026-02-05 | |
| 2025-12-31 | $16,237,341 | 15,109 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,526,000 | 2,000 | Put | Sole | 2025-11-04 | |
| 2025-09-30 | $10,727,017 | 14,059 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $12,067,903 | 15,481 | Shares | Sole | 2025-08-05 | |
| 2025-06-30 | $1,559,060 | 2,000 | Put | Sole | 2025-08-05 | |
| 2025-03-31 | $12,013,686 | 14,546 | Shares | Sole | 2025-04-17 | |
| 2025-03-31 | $825,910 | 1,000 | Put | Sole | 2025-04-17 | |
| 2024-12-31 | $11,189,368 | 14,494 | Shares | Sole | 2025-02-06 | |
| 2024-12-31 | $772,000 | 1,000 | Put | Sole | 2025-02-06 | |
| 2024-09-30 | $10,336,261 | 11,667 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $10,692,537 | 11,810 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $6,759,694 | 8,689 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $4,204,601 | 7,213 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $3,860,353 | 7,187 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $3,477,955 | 7,416 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $2,439,655 | 7,104 | Shares | Sole | 2023-04-07 | |
| 2022-12-31 | $2,655,998 | 7,260 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $2,317,126 | 7,166 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $2,153,535 | 6,642 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $1,975,953 | 6,900 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $1,665,330 | 6,029 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,286,948 | 5,570 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $1,250,654 | 5,449 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $994,816 | 5,325 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $765,689 | 4,535 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $603,477 | 4,077 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $743,735 | 4,530 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $544,337 | 3,924 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||